NewsRoom Articles - Page 593 of 1444

WednesdayOct 14, 2020 10:25 am

GreenLane Holdings (NASDAQ: GNLN) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

GreenLane Holdings (NASDAQ: GNLN) is a holding company which, through its subsidiaries, supplies vaporization products and accessories to dispensaries and smoke shops across the United States and Canada. Since being founded in 2005, the company has grown to over 300 employees with operations in thirteen cities across North America and Europe, including seven highly automated distribution centers. Aaron LoCascio, CEO of GreenLane Holdings, and Bill Mote, CFO of GreenLane Holdings, will be participating in a forum entitled “High Tech: Technology Changing the Game for the Cannabis Consumer” together with Brian Cissell at 365 Cannabis and moderated by Michael Aiello of…

WednesdayOct 14, 2020 9:00 am

Multi-Billion-Dollar Market Forecast in Psychedelic Therapeutics

NetworkNewsWire Editorial Coverage: Compelling evidence of the therapeutic benefits of psychedelic drugs appears in multiple scientific studies. Several clinical trials are underway in the United States and worldwide to investigate the therapeutic effects of psilocybin, the active component in the fungi known colloquially as "magic mushrooms." There is new hope for treating such debilitating disorders as depression, anxiety, post-traumatic stress disorder, anorexia, obsessive-compulsive disorder, and addiction. With more than $6.8 billion on the line by 2027, companies at the vanguard of the psychedelic therapeutic drug market could reap enormous benefits in the coming years. Some of these companies, such as…

TuesdayOct 13, 2020 2:01 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Takes Another Step Closer to Q1 Launch of Brain Cancer Drug Trial

CNS Pharmaceuticals is a pre-clinical-stage developer of novel brain cancer-fighting drugs, including its lead candidate Berubicin The company is working to build on promising results from a 2006 Phase I trial, which provided 44 percent of its limited patient pool with clinically significant improvement in disease stability and one patient with a durable complete response (no evidence of any tumor remaining) for over 14 years CNS Pharmaceuticals expects to launch a pivotal Phase II trial of Berubicin at the beginning of next year and has been assembling a team of partner companies help with the trial CNS recently announced that…

TuesdayOct 13, 2020 1:21 pm

Predictive Oncology Inc. (NASDAQ: POAI) CEO Schwartz Pens Letter to Shareholders, Elaborates on Ongoing Company Developments

Predictive Oncology’s CEO Carl Schwartz published open letter to company’s shareholders Schwartz elaborated on various developments within each of POAI’s divisions, has reiterated his optimism on company’s operations going forward CEO also revealed that company’s revenue trends have stabilized and are now on upward trend with cash burn beginning to decline Company also revealed its ability to access over $10 million in undrawn equity lines of credit Carl Schwartz, the CEO of Predictive Oncology (NASDAQ: POAI), a knowledge-driven medicine company that focuses on applying data and artificial intelligence (“AI”) to cancer personalized medicine and drug discovery, has recently published a…

TuesdayOct 13, 2020 12:52 pm

Kaival Brands Innovations Group Inc. (KAVL) Acquires Patent, Announces Lab, Enters Smoking Cessation Market

KAVL recently acquired patent, announced creation of wholly owned subsidiary to develop smoking cessation products. Company plans to create products that satisfy smokers but are free from nicotine’s addictive traits. CEO says company is excited to help “all nicotine users lead healthier and higher-quality lives.” The Centers for Disease Control and Prevention report that smoking is the leading cause of preventable death in the world today (https://nnw.fm/SajJo). With the help of new and innovative cessation products, the 7 million deaths that occur every year due to smoking could be prevented — and Kaival Brands Innovations Group (OTCQB: KAVL) is determined to do…

TuesdayOct 13, 2020 11:50 am

Sustainable Green Team Ltd. (SGTM) Expanding Operations Amid Global Recession

SGTM awarded contract for tree services in Lake County, Florida through subsidiary Central Florida Arborcare SGTM subsidiary Mulch Manufacturing recently awarded two additional packaging contracts Subsidiary ArborPro of Mississippi Inc. awarded contract for Hurricane Laura recovery efforts Q2 results include $12.3 million revenue and $3.4 million gross profit Sustainable Green Team (OTC: SGTM), a leading provider of environmentally-beneficial solutions for tree and storm waste disposal, recently announced that Central Florida Arborcare, its wholly-owned subsidiary, was awarded a one-year contract to supply tree trimming and related services to the county, renewable for an additional four times over a one-year period. Along…

TuesdayOct 13, 2020 9:00 am

Blockbuster Year and Bright Horizons for SPACs

NetworkNewsWire Editorial Coverage: The year 2020 has already seen 127 SPAC IPOs, which have collectively raised over $48.5 billion in proceeds — more than the past ten years combined. A special purpose acquisition company (SPAC) is essentially a blank-check company formed to raise capital through an IPO with the sole intent of buying or merging with another operating company. SPACs have evolved to become an expedited and cost-effective way of doing an M&A deal and have been utilized by multiple Wall Street heavyweights. Going public via a SPAC enables a company to get a deal done in weeks instead of…

MondayOct 12, 2020 2:11 pm

Pure Extract Technologies Awarded Standard Processing License by Health Canada, Eyes Expansion Plans

Pure Extract Technologies has been awarded Standard Processing License by Health Canada The license will enable the Company to produce, sell cannabis & hemp products to other Licenced Producers in its purpose-built facility located near Whistler, Canada Canada’s ability to export worldwide coupled with Company’s EU-GMP compliant facility makes Pure Extracts a natural partner for companies involved within international distribution Pure Extract Technologies, a privately held British Columbia-domiciled plant extraction company, announced that it had been awarded a Standard Processing Licence by Health Canada under the Cannabis Act, following an extensive and meticulous five-month application and vetting process (https://nnw.fm/HuykA). Pure…

MondayOct 12, 2020 1:12 pm

The Movie Studio (MVES) Seeks to Expand Footprint Within Burgeoning Online Streaming Sector

Deloitte published report earlier this year looking into growth trends driving the global TMT industry Study found that consumers have embraced online streaming platforms in 2020, with average customer subscribing to three streaming platforms The Movie Studio has sought to capitalize on sector’s growth through launch of its own streaming platform as well as through purchase of content aggregator, BINGE Networks LLC Deloitte ultimately expects online streaming sector to consolidate, with only handful of platforms taking lion’s share of market As the world progresses through what can only be described as a wildly tumultuous year, it is evident that trends,…

MondayOct 12, 2020 12:38 pm

Pac Roots Cannabis Corp. (CSE: PACR) Employs Specialized Proprietary Cultivation Techniques, Seeks to Deliver on Higher-Quality Product Portfolio

Pac Roots Cannabis Corp. dedicated to supplying higher-quality cannabis product PACR enters into strategic licensing agreement with Phenome One Corp, providing access to 350 meticulously-designed cultivars Company has also employed number of proprietary cultivation techniques to ensure quality of end products, which has contributed to PACR’s stellar industry reputation Since completing its RTO and being listed on the CSE in May of 2020, Pac Roots Cannabis Corp. (CSE: PACR) has established a strong reputation within the field of cannabis and hemp cultivation, leveraging upon the exceptional genetics of its specialized cultivars as well as an innovative proprietary cultivation technique to…

Financial news and publishing for public and private companies

Contact us: 512.354.7000